BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3348553)

  • 1. Barrett's ulcer.
    Maiorana A; Stephens JK; Little AG
    Am Surg; 1988 Mar; 54(3):178-9. PubMed ID: 3348553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenic heterogeneity of Barrett's ulcers. Apropos of 38 case reports].
    Ollyo JB; Fontolliet C; Monnier P; Bauerfeind P; Cilluffo T; Gonvers JJ; Savary M
    Schweiz Med Wochenschr; 1989 May; 119(21):747-51. PubMed ID: 2756403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's esophagus in children: a consequence of chronic gastroesophageal reflux.
    Dahms BB; Rothstein FC
    Gastroenterology; 1984 Feb; 86(2):318-23. PubMed ID: 6690359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery.
    Sampliner RE; Steinbronn K; Garewal HS; Riddell RH
    Am J Gastroenterol; 1988 May; 83(5):510-2. PubMed ID: 3364411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.
    Eisen GM; Sandler RS; Murray S; Gottfried M
    Am J Gastroenterol; 1997 Jan; 92(1):27-31. PubMed ID: 8995932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endoscopic & histopathologic features of esophageal ulcers. Considerations in 13 cases].
    Ressetta G; Ziza F; La Bruna D; Cortale M; Melato M; Bucconi S
    Ann Ital Chir; 1995; 66(6):831-7; discussion 838. PubMed ID: 8712599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux and Barrett's esophagus in developmentally disabled patients.
    Roberts IM; Curtis RL; Madara JL
    Am J Gastroenterol; 1986 Jul; 81(7):519-23. PubMed ID: 3487246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplastic Barrett's esophagus in scleroderma.
    Sprung DJ; Gibb SP
    Am J Gastroenterol; 1985 Jul; 80(7):518-22. PubMed ID: 4014100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
    Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
    Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus: clinical, endoscopic, histologic, manometric, and electrical potential difference characteristics.
    Herlihy KJ; Orlando RC; Bryson JC; Bozymski EM; Carney CN; Powell DW
    Gastroenterology; 1984 Mar; 86(3):436-43. PubMed ID: 6693010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
    Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric surgery does not increase the risk of developing Barrett's esophagus.
    Parrilla P; Liron R; Martinez de Haro LF; Ortiz A; Molina J; De Andrés B
    Am J Gastroenterol; 1997 Jun; 92(6):960-3. PubMed ID: 9177510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole.
    Lee FI; Isaacs PE
    Am J Gastroenterol; 1988 Sep; 83(9):914-6. PubMed ID: 3414644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux.
    Csendes A; Smok G; Burdiles P; Quesada F; Huertas C; Rojas J; Korn O
    Dis Esophagus; 2000; 13(1):5-11. PubMed ID: 11005324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
    Sampliner RE
    Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus in children with cystic fibrosis: not a coincidental association.
    Hassall E; Israel DM; Davidson AG; Wong LT
    Am J Gastroenterol; 1993 Nov; 88(11):1934-8. PubMed ID: 8237944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.